Are ipsilateral breast tumour invasive recurrences in young (≤40 years) women more aggressive than their primary tumours?

British Journal of Cancer

Volumn 97, Issue 8, 2007, Pages 1046-1052

  Sigal Zafrani, B ^a   Bollet, M A ^a   Antoni, G ^a   Savignoni, A ^a   Vincent Salomon, A ^a   Pierga, J Y ^a   Salmon, R ^a   Sastre Garau, X ^a   Fourquet, A ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breast cancer; Breast conserving treatment; Local recurrence; Young age

Indexed keywords

HORMONE RECEPTOR;

ADULT; ANALYTIC METHOD; ARTICLE; BREAST TUMOR; CANCER RECURRENCE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREMENOPAUSE; PRIORITY JOURNAL; TUMOR;

ADULT; AGE FACTORS; BREAST NEOPLASMS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 35348874237     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603991     Document Type: Article

References (36)

1. Antonini N, Jones H, Horiot JC, Poortmans P, Struikmans H, den Bogaert WV, Barillot I, Fourquet A, Jager J, Hoogenraad W, Collette L, Pierart M, Hart G, Bartelink H (2006) Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 82: 265-271
2. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345: 1378-1387
3. Bollet MA, Sigal-Zafrani B, Mazeau V, Savignoni A, de la Rochefordiere A, Vincent-Salomon A, Salmon R, Campana F, Kirova YM, Dendale R, Fourquet A (2007) Age remains the first prognostic factor for locoregional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. Radiother Oncol 82: 272-280
4. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087-2106
5. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
6. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R (1991) Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338: 327-331
7. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L (1986) Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 57: 1717-1724
8. Fourquet A, Campana F, Zafrani B, Mosseri V, Vielh P, Durand JC, Vilcoq JR (1989) Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 17: 719-725
9. Fredriksson I, Liljegren G, Arnesson LG, Emdin SO, Palm-Sjovall M, Fornander T, Holmqvist M, Holmberg L, Frisell J (2002) Local recurrence in the breast after conservative surgery - a study of prognosis and prognostic factors in 391 women. Eur J Cancer 38: 1860-1870
10. Frierson Jr HF, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC, Wilbur DC (1995) Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103: 195-198
11. Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kraus D, Kestin LL (2005) Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. Am J Clin Pathol 123: 679-689
12. Haffty BG, Carter D, Flynn SD, Fischer DB, Brash DE, Simons J, Ziegler AM, Fischer JJ (1993) Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int J Radiat Oncol Biol Phys 27: 575-583
13. Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C (1996) Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol 14: 52-57
14. Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK (2002) Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95: 2059-2067
15. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457-481
16. Komoike Y, Akiyama F, Iino Y, Ikeda T, Tanaka-Akashi S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H (2005) Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 12: 104-111
17. Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ (2006) Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy. Clin Cancer Res 12: 5705-5712
18. Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J (1997) Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57: 1597-1604
19. Millis RR, Barnes DM, Lampejo OT, Egan MK, Smith P (1998) Tumour grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 34: 548-553
20. Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF, Peterse HJ, Bartelink H, Brown PO, Chang HY, van de Vijver MJ (2006) Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8: R62
21. Oh JL, Bonnen M, Outlaw ED, Schechter NR, Perkins GH, Strom EA, Babiera G, Oswald MJ, Allen PK, Thames HD, Buchholz TA (2006) The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is 'young'? Int J Radiat Oncol Biol Phys 65: 1345-1352
22. Robbins P, Pinder S, de Klerk N, Dawkins H, Harvey J, Sterrett G, Ellis I, Elston C (1995) Histological grading of breast carcinomas : a study of interobserver agreement. Hum Pathol 26: 873-879
23. Schlechter BL, Yang Q, Larson PS, Golubeva A, Blanchard RA, de las Morenas A, Rosenberg CL (2004) Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol 22: 1830-1838
24. Shibata A, Tsai YC, Press MF, Henderson BE, Jones PA, Ross RK (1996) Clonal analysis of bilateral breast cancer. Clin Cancer Res 2: 743-748
25. Smith TE, Lee D, Turner BC, Carter D, Haffty BG (2000) True recurrence vs new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48: 1281-1289
26. Sobin LH, Wittekind C (2002) TNM Classification of Malignant Tumours. New-York: Wiley-Liss
27. Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim S (1996) Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res 56: 855-859
28. Touboul E, Buffat L, Belkacemi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pene F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M (1999) Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43: 25-38
29. van der Sijp JR, van Meerbeeck JP, Maat AP, Zondervan PE, Sleddens HF, van Geel AN, Eggermont AM, Dinjens WN (2002) Determination of the molecular relationship between multiple tumors within one patient is of clinical importance. J Clin Oncol 20: 1105-1114
30. van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, van der Kwast TH, Zwarthoff EC (2000) Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet 9: 2973-2980
31. Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F, Salvadori B (1995) Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87: 19-27
32. Vicini FA, Antonucci JV, Goldstein N, Wallace M, Kestin L, Krauss D, Kunzmann J, Gilbert S, Schell S (2007) The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy. Cancer 109: 1264-1272
33. Vincent-Salomon A, Rousseau A, Jouve M, Beuzeboc P, Sigal-Zafrani B, Freneaux P, Rosty C, Nos C, Campana F, Klijanienko J, Al Ghuzlan A, Sastre-Garau X (2004) Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy. Eur J Cancer 40: 1502-1508
34. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, Bing Oei S, Peterse HL, Pierart M, Poortmans PM, Struikmans H, Van den Bogaert W, Bartelink H (2003) Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 39: 932-944
35. Waldman FM, DeVries S, Chew KL, Moore II DH, Kerlikowske K, Ljung BM (2000) Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 92: 313-320
36. Whelan T, Clark R, Roberts R, Levine M, Foster G (1994) Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys 30: 11-16